In response to the SARS-CoV-2 outbreak, Sartorius has worked extensively with customers and stakeholders in the development of effective airborne detection solutions.
The critical role of RT-PCR during the SARS-CoV-2 pandemic demonstrates that PCR technology not only continues to evolve, but is growing to meet challenges of unprecedented scale and importance.
COVID-19 related products have and will continue to be at the forefront of life sciences research and therapeutic development. Here are some new product updates.
As SARS-CoV-2 virus shifts strategies, new products and technologies step up to the challenge
The past year has accelerated the development of certain trends and new technologies – notably advanced genetic sequencing products and solutions.
From humble roots to noble humanitarian cause, PCR has left an indelible impact on the world of science.
Innovations to confront the challenges of viral vaccine research today and tomorrow
Researchers have begun to dissect SARS-CoV-2 effects on the blood brain barrier, making use of innovative cell culture models, techniques, and equipment
The successful application of NGS technologies to a problem of this scale and scope speaks to the power of innovation. Here are a few new NGS solutions for COVID-19 research applications.
Mass spectrometry once again wields its might, combating the COVID-19 pandemic from multiple aspects. Here is a brief look at some of the method development and collaborative efforts that are leading the charge.
Research into SARS-CoV-2 spike protein and other areas are contributing to the development of viable vaccines, drugs, and therapeutic antibodies -- all benefiting from new glycan analysis and LC-MS solutions.
Understanding the strengths and limitations of real-time RT-PCR is essential for examining the current virus outbreak and for those that may emerge in the future.
The Virus Surface to a Novel COVID-19 Vaccine Candidate: The Journey of the SARS-CoV-2 Spike Protein
Intensive analysis of the spike protein led to the development of the first vaccine candidate approved for clinical trials. Perhaps overshadowed, is the unprecedented collaboration between academic scientists, government institutions, and private industry central to this remarkable work.
High-resolution cryo-electron microscopy imaging of the CoV spike protein complex has revealed both expected and novel structural elements – signifying capabilities previously not observed in this family of coronaviruses..